TG Therapeutics (TGTX) Reports Q3 Loss of $0.43
Tweet
Share
E-mailGet Alerts TGTX Hot Sheet
Join SI Premium – FREE
TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.43), versus ($0.48) reported last year.
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Visa deposits $405M into U.S. litigation escrow, adjusting stock rates
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
